» Articles » PMID: 38067114

Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance

Overview
Journal Cells
Publisher MDPI
Date 2023 Dec 9
PMID 38067114
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer stem cells (CSCs) are a rare cancer cell population, responsible for the facilitation, progression, and resistance of tumors to therapeutic interventions. This subset of cancer cells with stemness and tumorigenic properties is organized in niches within the tumor microenvironment (TME) and presents altered regulation in a variety of metabolic pathways, including glycolysis, oxidative phosphorylation (OXPHOS), as well as lipid, amino acid, and iron metabolism. CSCs exhibit similarities as well as differences when comparedto normal stem cells, but also possess the ability of metabolic plasticity. In this review, we summarize the metabolic characteristics of normal, non-cancerous stem cells and CSCs. We also highlight the significance and implications of interventions targeting CSC metabolism to potentially achieve more robust clinical responses in the future.

Citing Articles

Single-Cell Sequencing Reveals the Role of Radiation-Induced Stemness-Responsive Cancer Cells in the Development of Radioresistance.

Shi Z, Hu C, Liu J, Cheng W, Chen X, Liu X Int J Mol Sci. 2025; 26(4).

PMID: 40003899 PMC: 11855645. DOI: 10.3390/ijms26041433.


Activity-Based Bioluminescent Logic-Gate Probe Reveals Crosstalk Between the Inflammatory Tumor Microenvironment and ALDH1A1 in Cancer Cells.

Swartchick C, Dirak M, Wenger L, Tapia Hernandez R, Lee M, Chan J JACS Au. 2025; 5(1):320-331.

PMID: 39886570 PMC: 11775703. DOI: 10.1021/jacsau.4c01001.


Molecular Insights in the Anticancer Activity of Natural Tocotrienols: Targeting Mitochondrial Metabolism and Cellular Redox Homeostasis.

Chiaramonte R, Sauro G, Giannandrea D, Limonta P, Casati L Antioxidants (Basel). 2025; 14(1).

PMID: 39857449 PMC: 11760857. DOI: 10.3390/antiox14010115.


From Vessels to Neurons-The Role of Hypoxia Pathway Proteins in Embryonic Neurogenesis.

Stepien B, Wielockx B Cells. 2024; 13(7.

PMID: 38607059 PMC: 11012138. DOI: 10.3390/cells13070621.


Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics.

Tu S, Chen J, Singh S, Maraboyina S, Gokden N, Hsu P Cancers (Basel). 2024; 16(3).

PMID: 38339375 PMC: 10854810. DOI: 10.3390/cancers16030624.

References
1.
LeBleu V, OConnell J, Gonzalez Herrera K, Wikman H, Pantel K, Haigis M . PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 2014; 16(10):992-1003, 1-15. PMC: 4369153. DOI: 10.1038/ncb3039. View

2.
Lagadinou E, Sach A, Callahan K, Rossi R, Neering S, Minhajuddin M . BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013; 12(3):329-41. PMC: 3595363. DOI: 10.1016/j.stem.2012.12.013. View

3.
Tirinato L, Liberale C, Di Franco S, Candeloro P, Benfante A, La Rocca R . Lipid droplets: a new player in colorectal cancer stem cells unveiled by spectroscopic imaging. Stem Cells. 2014; 33(1):35-44. PMC: 4311668. DOI: 10.1002/stem.1837. View

4.
Li B, Cao Y, Meng G, Qian L, Xu T, Yan C . Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway. EBioMedicine. 2018; 39:239-254. PMC: 6355660. DOI: 10.1016/j.ebiom.2018.11.063. View

5.
Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View